Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life

Rationale: As clinical efficacy of probiotics and prebiotics is determined by their joint effects both on the mechanism of immune tolerance, gut inflammation and intestinal wall permeability, one of the objective methods to assess efficacy of probiotic strain-containing agents could be based on meas...

Full description

Bibliographic Details
Main Authors: N. B. Migacheva, D. V. Pechkurov, T. I. Kaganova, T. V. Sushkova
Format: Article
Language:Russian
Published: MONIKI 2017-02-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/472
_version_ 1818358907185135616
author N. B. Migacheva
D. V. Pechkurov
T. I. Kaganova
T. V. Sushkova
author_facet N. B. Migacheva
D. V. Pechkurov
T. I. Kaganova
T. V. Sushkova
author_sort N. B. Migacheva
collection DOAJ
description Rationale: As clinical efficacy of probiotics and prebiotics is determined by their joint effects both on the mechanism of immune tolerance, gut inflammation and intestinal wall permeability, one of the objective methods to assess efficacy of probiotic strain-containing agents could be based on measurement of fecal calprotectin levels.Aim: To evaluate changes in fecal calprotectin as an efficacy parameter of treatment with the Lactobacillus rhamnosus GG  – fructooligosacсharide complex for prevention of atopic dermatitis in infants.Materials and methods: Sixty healthy newborns from the risk group for allergic disorders were randomized (envelope randomization) into two groups: the infants from the control group (n = 31) were given widely used recommendations to prevent atopic dermatitis, whereas the infants from the study group (n = 29) were additionally administered a synbiotic containing Lactobacillus rhamnosus GG with fructooligosaccharides. The efficacy of the synbiotic therapy was assessed by measurement of fecal calprotectin levels at 3 and 6  months of the follow-up.Results: The first measurement of fecal calprotectin levels at 3 months showed its significant increase in all infants (mean 276.9 ± 128.8  mcg/G), compared to the normal range (below 50  mcg/G). The second measurement at 6  months demonstrated a  decrease in fecal calprotectin in infants from both groups (mean 75.8 ± 55.3 mcg/G). However, mean levels of fecal calprotectin in the infants from the study group who had been administered the synbiotic, was significantly lower than that in the control group (48.6 ± 38.5 and 99.7 ± 57.4  mcg/G, respectively; р < 0.05).Conclusion: The observed changes in fecal calprotectin levels support the positive role of synbiotics and lyophilized complex of Lactobacillus rhamnosus GG with fructooligosaccharides in the growth of gut microbiota in infants and in the reduction of inflammation, all of this being an important prerequisite for development of the oral tolerance mechanisms.
first_indexed 2024-12-13T20:36:27Z
format Article
id doaj.art-cfbb9606bd0943f983c7422fa4c7752c
institution Directory Open Access Journal
issn 2072-0505
2587-9294
language Russian
last_indexed 2024-12-13T20:36:27Z
publishDate 2017-02-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj.art-cfbb9606bd0943f983c7422fa4c7752c2022-12-21T23:32:16ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942017-02-01451333910.18786/2072-0505-2017-45-1-33-39420Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of lifeN. B. Migacheva0D. V. Pechkurov1T. I. Kaganova2T. V. Sushkova3Samara State Medical UniversitySamara State Medical UniversitySamara State Medical UniversitySamara City Children's Clinical Hospital No. 1 named after N.N. IvanovaRationale: As clinical efficacy of probiotics and prebiotics is determined by their joint effects both on the mechanism of immune tolerance, gut inflammation and intestinal wall permeability, one of the objective methods to assess efficacy of probiotic strain-containing agents could be based on measurement of fecal calprotectin levels.Aim: To evaluate changes in fecal calprotectin as an efficacy parameter of treatment with the Lactobacillus rhamnosus GG  – fructooligosacсharide complex for prevention of atopic dermatitis in infants.Materials and methods: Sixty healthy newborns from the risk group for allergic disorders were randomized (envelope randomization) into two groups: the infants from the control group (n = 31) were given widely used recommendations to prevent atopic dermatitis, whereas the infants from the study group (n = 29) were additionally administered a synbiotic containing Lactobacillus rhamnosus GG with fructooligosaccharides. The efficacy of the synbiotic therapy was assessed by measurement of fecal calprotectin levels at 3 and 6  months of the follow-up.Results: The first measurement of fecal calprotectin levels at 3 months showed its significant increase in all infants (mean 276.9 ± 128.8  mcg/G), compared to the normal range (below 50  mcg/G). The second measurement at 6  months demonstrated a  decrease in fecal calprotectin in infants from both groups (mean 75.8 ± 55.3 mcg/G). However, mean levels of fecal calprotectin in the infants from the study group who had been administered the synbiotic, was significantly lower than that in the control group (48.6 ± 38.5 and 99.7 ± 57.4  mcg/G, respectively; р < 0.05).Conclusion: The observed changes in fecal calprotectin levels support the positive role of synbiotics and lyophilized complex of Lactobacillus rhamnosus GG with fructooligosaccharides in the growth of gut microbiota in infants and in the reduction of inflammation, all of this being an important prerequisite for development of the oral tolerance mechanisms.https://www.almclinmed.ru/jour/article/view/472infantprobioticscalprotectin
spellingShingle N. B. Migacheva
D. V. Pechkurov
T. I. Kaganova
T. V. Sushkova
Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
Alʹmanah Kliničeskoj Mediciny
infant
probiotics
calprotectin
title Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
title_full Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
title_fullStr Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
title_full_unstemmed Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
title_short Effect of a synbiotic containing Lactobacillus rhamnosus GG and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
title_sort effect of a synbiotic containing lactobacillus rhamnosus gg and fructooligosaccharides on the dynamics of the level of fecal calprotectin in children of first year of life
topic infant
probiotics
calprotectin
url https://www.almclinmed.ru/jour/article/view/472
work_keys_str_mv AT nbmigacheva effectofasynbioticcontaininglactobacillusrhamnosusggandfructooligosaccharidesonthedynamicsoftheleveloffecalcalprotectininchildrenoffirstyearoflife
AT dvpechkurov effectofasynbioticcontaininglactobacillusrhamnosusggandfructooligosaccharidesonthedynamicsoftheleveloffecalcalprotectininchildrenoffirstyearoflife
AT tikaganova effectofasynbioticcontaininglactobacillusrhamnosusggandfructooligosaccharidesonthedynamicsoftheleveloffecalcalprotectininchildrenoffirstyearoflife
AT tvsushkova effectofasynbioticcontaininglactobacillusrhamnosusggandfructooligosaccharidesonthedynamicsoftheleveloffecalcalprotectininchildrenoffirstyearoflife